Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes

Juan Carlos Murciano, Sandra Medinilla, Donald Eslin, Elena Nikolaevna Atochina-Vasserman, Douglas B. Cines, Vladimir R. Muzykantov

Результат исследований: Материалы для журналаСтатья

111 Цитирования (Scopus)

Выдержка

A fibrinolytic agent consisting of a tissue-type plasminogen activator (tPA) coupled to the surface of red blood cells (RBCs) can dissolve nascent clots from within the clot, in a Trojan horse-like strategy, while having minimal effects on preexisting hemostatic clots or extravascular tissue. After intravenous injection, the fibrinolytic activity of RBC-tPA persisted in the bloodstream at least tenfold longer than did that of free tPA. In a model of venous thrombosis induced by intravenously injected fibrin microemboli aggregating in pulmonary vasculature, soluble tPA lysed pulmonary clots lodged before but not after tPA injection, whereas the converse was true for RBC-tPA. Free tPA failed to lyse occlusive carotid thrombosis whether injected before or after vascular trauma, whereas RBC-tPA circulating before, but not injected after, thrombus formation restored blood flow. This RBC-based drug delivery strategy alters the fibrinolytic profile of tPA, permitting prophylactic fibrinolysis.

Язык оригиналаАнглийский
Страницы (с-по)891-896
Число страниц6
ЖурналNature Biotechnology
Том21
Номер выпуска8
DOI
СостояниеОпубликовано - 1 авг 2003
Опубликовано для внешнего пользованияДа

Отпечаток

Plasminogen Activators
Fibrinolysis
Dissolution
Blood
Erythrocytes
Cells
Tissue
Carotid Artery Thrombosis
Drug delivery
Lung
Fibrinolytic Agents
Tissue Plasminogen Activator
Hemostatics
Fibrin
Intravenous Injections
Venous Thrombosis
Blood Vessels
Thrombosis
Injections
Wounds and Injuries

ASJC Scopus subject areas

  • Microbiology

Цитировать

Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. / Murciano, Juan Carlos; Medinilla, Sandra; Eslin, Donald; Atochina-Vasserman, Elena Nikolaevna; Cines, Douglas B.; Muzykantov, Vladimir R.

В: Nature Biotechnology, Том 21, № 8, 01.08.2003, стр. 891-896.

Результат исследований: Материалы для журналаСтатья

Murciano, Juan Carlos ; Medinilla, Sandra ; Eslin, Donald ; Atochina-Vasserman, Elena Nikolaevna ; Cines, Douglas B. ; Muzykantov, Vladimir R. / Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. В: Nature Biotechnology. 2003 ; Том 21, № 8. стр. 891-896.
@article{017adda081ce4dd6b937224e3a047fc7,
title = "Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes",
abstract = "A fibrinolytic agent consisting of a tissue-type plasminogen activator (tPA) coupled to the surface of red blood cells (RBCs) can dissolve nascent clots from within the clot, in a Trojan horse-like strategy, while having minimal effects on preexisting hemostatic clots or extravascular tissue. After intravenous injection, the fibrinolytic activity of RBC-tPA persisted in the bloodstream at least tenfold longer than did that of free tPA. In a model of venous thrombosis induced by intravenously injected fibrin microemboli aggregating in pulmonary vasculature, soluble tPA lysed pulmonary clots lodged before but not after tPA injection, whereas the converse was true for RBC-tPA. Free tPA failed to lyse occlusive carotid thrombosis whether injected before or after vascular trauma, whereas RBC-tPA circulating before, but not injected after, thrombus formation restored blood flow. This RBC-based drug delivery strategy alters the fibrinolytic profile of tPA, permitting prophylactic fibrinolysis.",
author = "Murciano, {Juan Carlos} and Sandra Medinilla and Donald Eslin and Atochina-Vasserman, {Elena Nikolaevna} and Cines, {Douglas B.} and Muzykantov, {Vladimir R.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1038/nbt846",
language = "English",
volume = "21",
pages = "891--896",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes

AU - Murciano, Juan Carlos

AU - Medinilla, Sandra

AU - Eslin, Donald

AU - Atochina-Vasserman, Elena Nikolaevna

AU - Cines, Douglas B.

AU - Muzykantov, Vladimir R.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - A fibrinolytic agent consisting of a tissue-type plasminogen activator (tPA) coupled to the surface of red blood cells (RBCs) can dissolve nascent clots from within the clot, in a Trojan horse-like strategy, while having minimal effects on preexisting hemostatic clots or extravascular tissue. After intravenous injection, the fibrinolytic activity of RBC-tPA persisted in the bloodstream at least tenfold longer than did that of free tPA. In a model of venous thrombosis induced by intravenously injected fibrin microemboli aggregating in pulmonary vasculature, soluble tPA lysed pulmonary clots lodged before but not after tPA injection, whereas the converse was true for RBC-tPA. Free tPA failed to lyse occlusive carotid thrombosis whether injected before or after vascular trauma, whereas RBC-tPA circulating before, but not injected after, thrombus formation restored blood flow. This RBC-based drug delivery strategy alters the fibrinolytic profile of tPA, permitting prophylactic fibrinolysis.

AB - A fibrinolytic agent consisting of a tissue-type plasminogen activator (tPA) coupled to the surface of red blood cells (RBCs) can dissolve nascent clots from within the clot, in a Trojan horse-like strategy, while having minimal effects on preexisting hemostatic clots or extravascular tissue. After intravenous injection, the fibrinolytic activity of RBC-tPA persisted in the bloodstream at least tenfold longer than did that of free tPA. In a model of venous thrombosis induced by intravenously injected fibrin microemboli aggregating in pulmonary vasculature, soluble tPA lysed pulmonary clots lodged before but not after tPA injection, whereas the converse was true for RBC-tPA. Free tPA failed to lyse occlusive carotid thrombosis whether injected before or after vascular trauma, whereas RBC-tPA circulating before, but not injected after, thrombus formation restored blood flow. This RBC-based drug delivery strategy alters the fibrinolytic profile of tPA, permitting prophylactic fibrinolysis.

UR - http://www.scopus.com/inward/record.url?scp=0042855871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042855871&partnerID=8YFLogxK

U2 - 10.1038/nbt846

DO - 10.1038/nbt846

M3 - Article

C2 - 12845330

AN - SCOPUS:0042855871

VL - 21

SP - 891

EP - 896

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 8

ER -